13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001104659-26-016303
Total Value
$1.31B
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | COGENT BIOSCIENCES INC | COGT | 9,003,418 | $319.8M | 24.34% |
| 2 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $154.6M | 11.77% |
| 3 | SPYRE THERAPEUTICS INC | SYRE | 4,018,101 | $131.6M | 10.02% |
| 4 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,914,458 | $121.8M | 9.27% |
| 5 | ORUKA THERAPEUTICS INC | ORKA | 3,705,262 | $112.3M | 8.55% |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 2,137,191 | $88.1M | 6.70% |
| 7 | ZENAS BIOPHARMA INC | ZBIO | 2,209,025 | $80.2M | 6.11% |
| 8 | NUVALENT INC | NUVL | 727,563 | $73.2M | 5.57% |
| 9 | JADE BIOSCIENCES INC | JBIO | 4,553,494 | $70.3M | 5.35% |
| 10 | ENLIVEN THERAPEUTICS INC | ELVN | 3,711,444 | $57.2M | 4.35% |
| 11 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 1,319,688 | $54.4M | 4.14% |
| 12 | CRESCENT BIOPHARMA INC. | CBIO | 2,747,866 | $32.6M | 2.48% |
| 13 | INHIBIKASE THERAPEUTICS INC | IKT | 8,625,000 | $17.7M | 1.35% |